Novo Nordisk sues Eli Lilly over advertising
It’s a legal battle between weight-loss drug heavyweights the maker of Wegovy is suing Zepbound manufacturer Eli Lilly.
It’s a legal battle between weight-loss drug heavyweights the maker of Wegovy is suing Zepbound manufacturer Eli Lilly.
CVS is adding two weight-loss options to its drug plans.
The FDA wants suicide warnings to be taken off of some popular weight-loss medications.
A new University of Oxford review of research says many patients will return to their starting weight within two years of ending the treatment.
Two popular weight loss drugs will now cost less, that is if you pay with cash instead of going through insurance.
The Food and Drug Administration has issued a warning about approved treatments for diabetes and weight loss.